KS.1.1/JN.1* recombinant (337 seqs, >10 places, 16% South Korea 8% Hong Kong)

[xz-keg]

From sars-cov-2-variants/lineage-proposals#1806

KS.1.1--JN.1

Breakpoint between 22929 and 24820

Additional mutations: C6701T, C19716T, T25510C, C29311T

Orf1a:L2146F, Orf3a:S40P

C6701T, C19716T from a KS.1.1 branch,
One of T25510C, C29311T from a JN.1* branch, the other is private.

GISAID query: T25510C, C29311T,C19716T,T3565C
No. of seqs: 56(Canada 1 Japan 2 Russia 1 China 1 USA 7(2 from South Korea 1 from France) Netherlands 1 South Korea 41 Ireland 1 Israel 1)

First: EPI_ISL_19257990, South Korea, 2024-6-17
Latest: EPI_ISL_19352398, South Korea, 2024-8-3

30/556 of South Korean seqs after 7/20.
usher

[FedeGueli]

61 now,
to be noticed that the last two GBW samples from Korea both carry S:K458N .
Query for them: C1960T, T25510C, G22936T

[xz-keg]

86, Singapore,

[xz-keg]

South Korea prevalence climbs from 5% to 24/262=9% in seqs sampled after 8-1

[FedeGueli]

87 Finland

[xz-keg]

@corneliusroemer @AngieHinrichs This recomb is now placed under JN.1.18.6, but due to C6701T, C19716T and S:T22N,F59S it is still better explained as KS.1.1/JN.1* recombinant. When designation please be careful and not designate it as JN.1.18.6 descendant.

[xz-keg]

96, Denmark, Australia

[FedeGueli]

123 now , Denmark

[xz-keg]

Also in Germany